EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of allergic lung disease mice with splenic CD8-alpha-positive dendritic cells down-regulates pulmonary Th2 responses and airway hyperresponsiveness



Treatment of allergic lung disease mice with splenic CD8-alpha-positive dendritic cells down-regulates pulmonary Th2 responses and airway hyperresponsiveness



FASEB Journal 18(4-5): Abst 769 8



As antigen-presenting cells, dendritic cells (DC) can either initiate and tolerize immune responses, depending on their phenotype -- freshly purified CD8-alpha-positive DC (CD8+DC), but not CD8-neg. DC, reportedly reduce the cytokine release and proliferative responses of lymphocytes to antigen challenge. Based on this evidence, we hypothesized that allergen-pulsed CD8+ DC might also down-regulate allergic lung disease (ALD) in mice. ALD was induced in BALB/c mice with two ip doses of OVA-alum (dy 0, 14), and three exposures to OVA aerosols. The mice displayed airway hyperresponsiveness (AHR), and Th2 responses, including eosinophilia and circulating OVA-specific IgE/IgG1. We purified CD8+DC (or CD8-neg. DC) from normal BAL/c mice using differential adherence and MACS, pulsed them with OVA, characterized them in vitro, then treated ALD mice intratracheally with varying numbers of these cells. In vitro, the CD8+DC expressed lower levels of CD80 and CD86 than did CD8-neg DC, but similar levels of CD40 and MHC-II. Perhaps not unexpectedly, the circulating OVA-specific IgG1 and IgE levels of the ALD mice were not markedly reduced 1-2 weeks following the splenic CD8+DC treatments, but the BAL levels of IL-5, IL-9, and IL-13 were remarkably depressed, and the BAL eosinophilia was reduced by 35-45%, relative to saline or CD8-neg DC-treated animals. Neither IFN-gamma nor IL-12 responses were detected in the airways of the treated animals, but there was a very marked augmentation of the OVA-specific IgA response. The AHR of the CD8+ DC-treated, but not CD8-neg DC-treated, mice was reduced dramatically; in some experiments as few as 10e4 CD8+ DC abrogated AHR to methacholine. (supported by the Saskatchewan Lung Association).

(PDF 0-2 workdays service: $29.90)

Accession: 035980908

Download citation: RISBibTeXText



Related references

Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. Faseb Journal 16(10): 1313-1315, 2002

Induction of pulmonary allergen-specific IgA responses or airway hyperresponsiveness in the absence of allergic lung disease following sensitization with limiting doses of ovalbumin-alum. Cellular Immunology 212(2): 101-109, 2001

Tolerogenic bone marrow-derived dendritic cells modulate TH2 responses of pulmonary lymphocytes from mice with severe allergic lung disease. FASEB Journal 18(4-5): Abst 769 15, 2004

CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. Journal of Immunology 175(3): 1516-1522, 2005

Dissociation of eosinophilia and airway hyperresponsiveness; eosinophil-deficient mice exhibit normal airway responses in a murine model of allergic airways disease. Inflammation Research 52(Supplement 2): S 144, July, 2003

Dissociation of pulmonary late allergic responses lar and airway hyperresponsiveness by treatment with dexamethasone. Pediatric Research 29(4 PART 2): 377A, 1991

Interactions between epithelial cells and dendritic cells in airway immune responses: lessons from allergic airway disease. Allergy 63(9): 1124-1135, 2008

IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. Journal of Allergy and Clinical Immunology 119(5): 1241-1250, 2007

Exacerbation of airway hyperresponsiveness and lung fibrosis by IL-18 neutralization in a chronic model of Aspergillus fumigatus-induced allergic airway disease. FASEB Journal 14(4): A601, March 15, 2000

Role of sensitized CD4+ T cells in the development and maintenance of pulmonary eosinophilia and allergic airway hyperresponsiveness following primary and secondary airway challenge. Journal of Allergy & Clinical Immunology 111(2 Abstract Supplement): S305, February, 2003

Flt3 Ligand (Flt3-L) Regulates Migratory Pattern of Lung Dendritic Cells in a Mouse Model of Allergic Airway Inflammation. Journal of Allergy and Clinical Immunology 123(2): S222-S222, 2009

Dendritic cells from mycobacteria-infected mice inhibits established allergic airway inflammatory responses to ragweed via IL-10- and IL-12-secreting mechanisms. Journal of Immunology 184(12): 7288-7296, 2010

Ferulic Acid Induces Th1 Responses by Modulating the Function of Dendritic Cells and Ameliorates Th2-Mediated Allergic Airway Inflammation in Mice. Evidence-Based Complementary and Alternative Medicine 2015: 678487-678487, 2015

Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease. Mediators of Inflammation 8(3): 133-146, 2000

Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. American Journal of Respiratory Cell and Molecular Biology 25(5): 600-605, 2001